lungview.com

What It Is

LungView is a healthcare management software suite designed for lung cancer screening programs and nodule clinics. Its target users are mainly hospitals, imaging centers, and radiology-related teams. Rather than being a general-purpose SaaS product, it is built around patient data collection, imaging result management, follow-up tracking, reporting, and compliance workflows in early lung cancer screening, helping organizations reduce manual data entry and process gaps.

Core Features and Integrations

Based on the information on its official website, LungView’s core modules include patient tracking software, Lung-RADS reporting and management, lung screening workflow automation, data analytics, and uploads to the ACR Lung Cancer Screening Registry. Integration is a key selling point: it can connect with EHR, PACS, reporting tools, and other clinical systems, and supports bidirectional data exchange with HL7-compatible HIS, RIS, EMR, and PACS systems. The system also mentions automatic import of patient data, medical history, and exam findings reports, as well as support for radiation dose data recording and dictation data extraction. These capabilities can help reduce duplicate entry and improve consistency in reporting and follow-up.

Pricing, Trial, and Deployment

The website does not disclose plans, pricing, contract terms, or whether billing is based on institution, user count, or exam volume. It also does not state whether a free version is available. The site includes multiple “Request a Demo” prompts, suggesting that it most likely uses a sales-led pricing model for healthcare organizations. Deployment options are also not clearly specified, so it is not possible to determine whether it is cloud-only, self-hosted, or hybrid.

Pros and Cons

The main advantage is its highly focused use case, covering key parts of the lung cancer screening process from patient tracking and report management to compliance uploads. It also emphasizes seamless integration with existing clinical systems, making it suitable for organizations that do not want to replace their current EHR/PACS/RIS stack. The downside is that publicly available information is incomplete, especially around procurement-critical details such as security certifications, HIPAA compliance or audit mechanisms, permission management, API documentation, and service/support SLAs.

Who It’s For and Access from China

LungView is suited to hospitals and imaging centers that already run lung cancer screening programs and need standardized Lung-RADS reporting and follow-up management. Its accessibility from China is unknown, and payment methods and localized services are not disclosed. Chinese organizations evaluating similar solutions should also review lung nodule screening modules from their existing HIS/RIS/PACS vendors, regional imaging platforms, or domestic healthcare IT alternatives, with particular attention to compliance, cross-border data transfer, and local implementation support.